Gene editing in allergic diseases: Identification of novel pathways and impact of deleting allergen genes

This publication has 101 references indexed in Scilit:

• Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections
  Biomedicine & Pharmacotherapy, 2022
• A novel therapeutic modality using CRISPR-engineered dendritic cells to treat allergies
  Biomaterials, 2021
• A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
  Cell Reports, 2018
• Contribution of Molecular Allergen Analysis in Diagnosis of Milk Allergy
  Current Allergy and Asthma Reports, 2017
• Detection of on-target and off-target mutations generated by CRISPR/Cas9 and other sequence-specific nucleases
  Biotechnology Advances, 2017
• Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR/Cas9-Enhanced Gene Targeting
  Cell Reports, 2015
• Cow’s milk allergy: evidence-based diagnosis and management for the practitioner
  European Journal of Pediatrics, 2014
• CRISPR/Cas9‐mediated genome engineering: An adeno‐associated viral (AAV) vector toolbox
  Biotechnology Journal, 2014
• Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
  Cell, 2014
• Identification and characterization of a second major peanut allergen, Ara h II, with use of the sera of patients with atopic dermatitis and positive peanut challenge
  Journal of Allergy and Clinical Immunology, 1992